Gravitas Collective Discloses 19.9% Stake in Hepion Pharmaceuticals
Gravitas Collective Corp. reported a 19.9% stake in Hepion Pharmaceuticals, receiving 25 million shares in exchange for its membership interests in Gravitas Life Sciences. The exchange took place on October 6, 2026.